Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Metabolomics and Mass Spectrometry Studies, Lipid metabolism and disorders, and Gut microbiota and health.
Gastric cancer risk associated with autoimmune gastritis-predisposing HLA alleles: a national prospective cohort study
L-NAME improves the morphology and necrosis of skeletal muscle by activating PINK1-PARKIN mediated mitophagy in mdx mice
Risk of gastric cancer in autoimmune gastritis and pernicious anaemia: Insights from Mendelian randomization and multi‐omics analysis
Multidimensional Optimization Strategies in Laser-Directed Energy Deposition: Enhancing Material Strength, Toughness, and Process Efficiency
Ni-Co-6–4 catalyst with crystalline-amorphous interfaces for efficient hydrazine electrooxidation
Cause-specific mortality in lean individuals with metabolic dysfunction-associated steatotic liver disease.
The role of deoxycholic acid in macrophage polarization and remodeling of the tumor microenvironment during colorectal adenoma-carcinoma transition.
Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial
Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice.
Investigation of Residual Stress Distribution and Fatigue of 7050-T7451 Alloy Hole Components with Laser Shock and Ultrasonic Extrusion
Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing Phosphorylation in the AKT Pathway.
Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
The Landscape of Gut Microbiota and Its Metabolites: A Key to Understanding the Pathophysiology of Pattern in Chinese Medicine.
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes.
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 72position: last
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.
Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease.
Comprehensive analysis of 5-hydroxymethylcytosine in zw10 kinetochore protein as a promising biomarker for screening and diagnosis of early colorectal cancer.
Therapeutic effects of herbal formula Huangqisan on metabolic disorders via SREBF1, SCD1 and AMPK signaling pathway
The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks.
Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome